JBM (Healthcare) Limited (2161.HK)
HKD 1.97
(4.23%)
HKD 1.97
(4.23%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 319.41 Million HKD | 69.97% |
| 2022 | 187.92 Million HKD | 32.06% |
| 2021 | 142.3 Million HKD | -21.35% |
| 2020 | 180.94 Million HKD | -4.86% |
| 2019 | 190.17 Million HKD | 12.08% |
| 2018 | 169.68 Million HKD | 16.07% |
| 2017 | 146.18 Million HKD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 Q2 | 171.12 Million HKD | 0.0% |
| 2023 FY | 319.41 Million HKD | 69.97% |
| 2023 Q4 | 166.95 Million HKD | 0.0% |
| 2022 FY | 187.92 Million HKD | 32.06% |
| 2022 Q4 | 119.96 Million HKD | 0.0% |
| 2022 Q2 | 85.54 Million HKD | 0.0% |
| 2021 Q2 | 75.08 Million HKD | 0.0% |
| 2021 FY | 142.3 Million HKD | -21.35% |
| 2021 Q4 | 86.43 Million HKD | 0.0% |
| 2020 Q2 | 102.4 Million HKD | 0.0% |
| 2020 Q4 | 96.02 Million HKD | 0.0% |
| 2020 FY | 180.94 Million HKD | -4.86% |
| 2019 FY | 190.17 Million HKD | 12.08% |
| 2018 FY | 169.68 Million HKD | 16.07% |
| 2017 FY | 146.18 Million HKD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Pak Fah Yeow International Limited | 167.43 Million HKD | -90.769% |
| Grand Pharmaceutical Group Limited | 6.52 Billion HKD | 95.104% |
| Extrawell Pharmaceutical Holdings Limited | 28.77 Million HKD | -1009.893% |
| Wai Yuen Tong Medicine Holdings Limited | 394.81 Million HKD | 19.097% |
| Qianhai Health Holdings Limited | -35.6 Million HKD | 997.16% |
| Lee's Pharmaceutical Holdings Limited | 551.31 Million HKD | 42.062% |
| Essex Bio-Technology Limited | 1.53 Billion HKD | 79.249% |
| Tongfang Kontafarma Holdings Limited | 471.29 Million HKD | 32.225% |
| PuraPharm Corporation Limited | 216.62 Million HKD | -47.448% |
| SSY Group Limited | 3.48 Billion HKD | 90.846% |
| Jacobson Pharma Corporation Limited | 620.47 Million HKD | 48.521% |
| China Resources Pharmaceutical Group Limited | 43.36 Billion HKD | 99.263% |